Clinical Trial 55454

Webster, TX 77598


Summary:

Have you been diagnosed with plaque psoriasis?  You are not alone.  Plaque psoriasis is a global health problem. The IM032-041 study is investigating a study drug that could help manage this autoimmune disease.  The IM032-041 clinical study is testing an investigational treatment to learn more about its effectiveness and safety when given to adults living with plaque psoriasis. 


Qualified Participants Must:

• Are 18 to 70 years of age
• Have been diagnosed with plaque psoriasis for at least 6 months
• Have plaques that cover at least 10% of your body


Qualified Participants May Receive:

Study-related exams and study-related medication at no cost to them. Reimbursement for time and travel may be available if you qualify.The study doctor and staff can explain to you in greater detail other requirements and eligibility criteria you would have to meet to take part in the study.


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.